07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
Client Alert: SBA to Enact Significant Changes to Small Business Regulations Before 2020: Everything...
Read More >
Seyfarth Synopsis: Knowledge that a competitor or former employee is misappropriating trade secrets ...
Read More >
The Situation It was recently reported that an Australian proxy adviser had queried whether the dire...
Read More >
Jonesboro Supermarket Refused to Accommodate Disabled Employee and Unlawfully Fired Him, Federal Age...
Read More >
On September 10, 2019, the National Labor Relations Board (the “Board”) adopted the “contract cov...
Read More >
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors ar...
Read More >